J Mark FitzGerald

3.4k citations

46 papers · 2.3k indexed · 1 hit paper · h-index 22

Physiology top 1%
Pulmonary and Respiratory Medicine top 2%
Immunology top 5%
Immunology and Allergy top 1%
Surgery top 10%

Co-authors: Louis‐Philippe Boulet Mohsen Sadatsafavi Donald W. Cockcroft Paul M. O’Byrne Beth E. Davis Gail M. Gauvreau Carlo A. Marra Richard Leigh
Topics: Asthma and respiratory diseases (19 papers)Respiratory and Cough-Related Research (10 papers)Chronic Obstructive Pulmonary Disease (COPD) Research (10 papers)
Cited by: Immunology and Allergy Physiology Pulmonary and Respiratory Medicine
Journals: New England Journal of Medicine American Journal of Respiratory and Critical Care Medicine CHEST Journal
Partner nations: Canada United States Australia

In The Last Decade

J Mark FitzGerald

45 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effects of an Anti-TSLP Antibody on Allergen-Induced Asthmatic Responses

2014 587 citations Gail M. Gauvreau, Paul M. O’Byrne et al. profile →

Peers

Countries citing papers authored by J Mark FitzGerald

Since Specialization

Citations

This map shows the geographic impact of J Mark FitzGerald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Mark FitzGerald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Mark FitzGerald more than expected).

Fields of papers citing papers by J Mark FitzGerald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Mark FitzGerald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Mark FitzGerald. The network helps show where J Mark FitzGerald may publish in the future.

Co-authorship network of co-authors of J Mark FitzGerald

This figure shows the co-authorship network connecting the top 25 collaborators of J Mark FitzGerald. A scholar is included among the top collaborators of J Mark FitzGerald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Mark FitzGerald. J Mark FitzGerald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Can we predict who will benefit most from biologics in severe asthma? A post-hoc analysis of two phase 3 trials 2023 ·Respiratory Research ·Wenjia Chen,Helen K. Reddel,J Mark FitzGerald,Richard Beasley,Christer Janson,Mohsen Sadatsafavi	6
2	Baseline FeNO Independently Predicts the Dupilumab Response in Patients With Moderate-to-Severe Asthma 2022 ·The Journal of Allergy and Clinical Immunology In Practice ·Ian Pavord,Yamo Deniz,Jonathan Corren,Thomas B. Casale,J Mark FitzGerald,(unknown),Nadia Daizadeh,Benjamin Ortiz,Robert R. Johnson,Sivan Harel,Michel Djandji,(unknown),(unknown),Paul J. Rowe,William W. Busse	54
3	Assessing factors influencing smoking and smoking cessation within Chinese communities in the Greater Vancouver Area: A qualitative exploratory study 2020 ·Tobacco Prevention & Cessation ·(unknown),Iraj Poureslami,Jessica Shum,(unknown),(unknown),J Mark FitzGerald	7
4	<p>Trends in prescriptions and costs of inhaled medications in chronic obstructive pulmonary disease: a 19-year population-based study from Canada</p> 2019 ·International Journal of COPD ·Hamid Tavakoli,KATE JOHNSON,J Mark FitzGerald,Don D. Sin,Andrea S. Gershon,Tetyana Kendzerska,Mohsen Sadatsafavi	18
5	Benralizumab Reduces Exacerbations in Japanese Patients with Severe, Uncontrolled Asthma: Subgroup Analysis of the Calima Trial 2017 ·Journal of Allergy and Clinical Immunology ·J Mark FitzGerald,Ken Ohta,Mitsuru Adachi,Yuji Tohda,Tadashi Kamei,Motokazu Kato,(unknown),(unknown),Nobuyuki Imai,Yanping Wu,Magnus Aurivillius,Mitchell Goldman	1
6	Assessing the effect of culturally specific audiovisual educational interventions on attaining self-management skills for chronic obstructive pulmonary disease in Mandarin- and Cantonese-speaking patients: a randomized controlled trial 2016 ·International Journal of COPD ·Iraj Poureslami,S.Y.L. Kwan,Stephen Lam,Nadia Khan,J Mark FitzGerald	32
7	The Projected Epidemic of Chronic Obstructive Pulmonary Disease Hospitalizations over the Next 15 Years. A Population-based Perspective 2016 ·American Journal of Respiratory and Critical Care Medicine ·Amir Khakban,Don D. Sin,J Mark FitzGerald,Bruce M. McManus,Raymond T. Ng,Zsuzsanna Hollander,Mohsen Sadatsafavi	86
8	TUBERCULOSIS screening preferences of Healthcare workers in South Africa: a best-worst scaling study to analyze variation by Occupation 2015 ·Value in Health ·Nathan N. O’Hara,(unknown),Lyndsay M. O’Hara,Jerry Spiegel,Larry D. Lynd,J Mark FitzGerald,Annalee Yassi,(unknown),Carlo A. Marra	1
9	A Systems Approach to Chronic Obstructive Pulmonary Disease (COPD) Management in Vancouver and the Lower Mainland (LM): The COPD Lower Mainland Innovation and Integration Fund (LMIIF) Project 2010 ·CHEST Journal ·(unknown),J Mark FitzGerald	1
10	Effects of Interleukin-13 Blockade on Allergen-induced Airway Responses in Mild Atopic Asthma 2010 ·American Journal of Respiratory and Critical Care Medicine ·Gail M. Gauvreau,Louis‐Philippe Boulet,Donald W. Cockcroft,J Mark FitzGerald,Chris Carlsten,Beth E. Davis,Francine Deschesnes,MyLinh Duong,Billie L. Durn,Karen Howie,(unknown),Marion T. Kasaian,Kieran J. Killian,Tara X. Strinich,Richard M. Watson,(unknown),Simon Zhou,Donald G. Raible,Paul M. O’Byrne	181
11	Falls in people with chronic obstructive pulmonary disease: An observational cohort study 2010 ·Respiratory Medicine ·Marc Roig,Janice J. Eng,Donna L. MacIntyre,Jeremy Road,J Mark FitzGerald,Jennifer Burns,W. Darlene Reid	129
12	Direct Health Care Costs Associated with Asthma in British Columbia 2010 ·Canadian Respiratory Journal ·Mohsen Sadatsafavi,Larry D. Lynd,Carlo A. Marra,Bruce Carleton,Wan C. Tan,Sean D. Sullivan,J Mark FitzGerald	123
13	Cost‐Effectiveness of Continuous Positive Airway Pressure Therapy in Patients with Obstructive Sleep Apnea‐Hypopnea in British Columbia 2008 ·Canadian Respiratory Journal ·(unknown),(unknown),Alan Mulgrew,(unknown),J Mark FitzGerald,(unknown),Michael Schulzer,C. Francis Ryan,(unknown),(unknown),Carlo A. Marra	37
14	The impact of obstructive sleep apnea and daytime sleepiness on work limitation 2007 ·Sleep Medicine ·Alan Mulgrew,C. Francis Ryan,John A. Fleetham,R. Cheema,Noam Y. Fox,Mieke Koehoorn,J Mark FitzGerald,Carlo A. Marra,Najib Ayas	175
15	The risk of death associated with delayed coronary artery bypass surgery 2006 ·BMC Health Services Research ·Boris Sobolev,Adrian R. Levy,Lisa Kuramoto,Robert Hayden,James M. Brophy,J Mark FitzGerald	25
16	Do Longer Delays for Coronary Artery Bypass Surgery Contribute to Preoperative Mortality in Less Urgent Patients? 2006 ·Medical Care ·Boris Sobolev,Adrian R. Levy,Lisa Kuramoto,Robert Hayden,J Mark FitzGerald	18
17	Research Gaps in Protecting Healthcare Workers From SARS and Other Respiratory Pathogens: An Interdisciplinary, Multi-Stakeholder, Evidence-Based Approach 2005 ·Journal of Occupational and Environmental Medicine ·Annalee Yassi,David Moore,J Mark FitzGerald,Philip Bigelow,Chun‐Yip Hon,Elizabeth Bryce	68
18	Time on wait lists for coronary bypass surgery in British Columbia, Canada, 1991 – 2000 2005 ·BMC Health Services Research ·Adrian R. Levy,Boris Sobolev,Robert Hayden,(unknown),J Mark FitzGerald,Martin T. Schechter	27
19	Tuberculosis among Aboriginal and Nonaboriginal Persons in British Columbia 2000 ·Canadian Respiratory Journal ·(unknown),Kukuh Noertjojo,(unknown),J Mark FitzGerald	8
20	The Effect of Adding Ipratropium Bromide to Salbutamol in the Treatment of Acute Asthma 1998 ·CHEST Journal ·Stephan Lanes,Jeffrey Garrett,Charles Wentworth,J Mark FitzGerald,Jill P. Karpel	52

About J Mark FitzGerald

J Mark FitzGerald is a scholar working on Issues, ethics and legal aspects, Physiology and Immunology and Allergy, having authored 46 papers that have together received 2.3k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (19 papers), Respiratory and Cough-Related Research (10 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (10 papers). The work is most often cited by research in Immunology and Allergy (377 citations), Physiology (1.4k citations) and Pulmonary and Respiratory Medicine (1.0k citations). J Mark FitzGerald has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Louis‐Philippe Boulet, Mohsen Sadatsafavi, Donald W. Cockcroft, Paul M. O’Byrne, Beth E. Davis, Gail M. Gauvreau, Carlo A. Marra, Richard Leigh, Michael Boedigheimer and Michael R. Comeau. Their work appears in journals such as New England Journal of Medicine, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact